Siegfried Reich
VP, Drug Discovery, SGX PHARMACEUTICALS, INC.
Companies
- Turning Point Therapeutics, Inc.EVP & Chief Scientific Officer Mar 2, 2020 to Feb 11, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Turning Point Therapeutics, Inc.17,015 shares2Feb 9, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 9, 2022Granted 13,567 shares of Turning Point Therapeutics, Inc.2
- Feb 9, 2022Sold 397 shares at $36.30 of Turning Point Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2